Keros Therapeutics, Inc. (KROS) Earnings
NASDAQ·Healthcare·Biotechnology
$11.64
-0.77%
Mkt Cap $358.06M
EPS — Estimate vs Actual
Mkt Cap
$358.06M
P/E
4.44
Fwd P/E
4.76
P/S
10.79
Rev TTM
—
EPS TTM
-$1.95
NASDAQ·Healthcare·Biotechnology
$11.64
-0.77%
Mkt Cap $358.06M
Mkt Cap
$358.06M
P/E
4.44
Fwd P/E
4.76
P/S
10.79
Rev TTM
—
EPS TTM
-$1.95